Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02228096
Title Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients
Acronym ENSIGN
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Childrens Hospital Los Angeles SC Los Angeles California 90027 United States Details
Stanford University Medical Center Palo Alto California 94304 United States Details
Children's Healthcare of Atlanta SC-2 Atlanta Georgia 30342 United States Details
University of Michigan Ann Arbor Michigan 48109-5941 United States Details
University of Minnesota Medical Center Minneapolis Minnesota 55455 United States Details
Mercy Children's Kansas University Kansas City Missouri 64108 United States Details
Duke University Medical Center Durham North Carolina 27708 United States Details
Cincinnati Children's Hospital Cincinnati Ohio 45230 United States Details
Oregon Health and Science University SC Portland Oregon 97239 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
University of Texas Southwestern Medical Center SC Dallas Texas 75390-9034 United States Details
University of Utah Salt Lake City Utah 84113 United States Details
University of Wisconsin Hospital and Clinics Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field